{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:27Z","timestamp":1786985427078,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bmc.2024.118020","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:40:34Z","timestamp":1732642834000},"page":"118020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis of aromatic glycoconjugates as anti-fungal agents against Candida spp. and assessment of their covalent crosslinking capabilities"],"prefix":"10.1016","volume":"117","author":[{"given":"Kyle","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keela","family":"Kessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlei","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliwier","family":"Dulawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6413-3660","authenticated-orcid":false,"given":"Kaja","family":"Kasemets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0701-8268","authenticated-orcid":false,"given":"Trinidad","family":"Velasco-Torrijos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.118020_b0005","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.118020_b0010","series-title":"Overcoming obstacles in drug discovery and development","first-page":"51","article-title":"Drug development of covalent inhibitors","author":"Dahal","year":"2023"},{"key":"10.1016\/j.bmc.2024.118020_b0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41586-021-03899-0","article-title":"Rational design of a new antibiotic class for drug-resistant infections","volume":"597","author":"Durand-Reville","year":"2021","journal-title":"Nat"},{"key":"10.1016\/j.bmc.2024.118020_b0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1039\/D1MD00200G","article-title":"\u03b2-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates","volume":"12","author":"Mora-Ochomogo","year":"2021","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0025","first-page":"1478","article-title":"Extended applications of small-molecule covalent inhibitors toward novel therapeutic targets","volume":"15","author":"Lee","year":"2022","journal-title":"Pharm (Basel)"},{"key":"10.1016\/j.bmc.2024.118020_b0030","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/acschembio.9b00982","article-title":"Discovery of novel antibiotics as covalent inhibitors of fatty acid synthesis","volume":"15","author":"Wang","year":"2020","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2024.118020_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114752","article-title":"Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead","volume":"243","author":"Grabrijan","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112573","article-title":"Structure-based design of covalent inhibitors targeting metallo-\u03b2-lactamases","volume":"203","author":"Chen","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0045","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1021\/acs.jmedchem.8b01153","article-title":"Emerging and re-emerging warheads for targeted covalent inhibitors: applications in medicinal chemistry and chemical biology","volume":"62","author":"Gehringer","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ddr.21875","article-title":"Design and testing of selective inactivators against an antifungal enzyme target","volume":"83","author":"Friday","year":"2022","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2024.118020_b0055","article-title":"Small-molecule inhibitors for the Prp8 intein as antifungal agents","volume":"118","author":"Li","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2024.118020_b0060","article-title":"Recent advances in the development and synthesis of carbohydrate-based molecules with promising antibacterial activity","volume":"26","author":"de Matos","year":"2023","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202200795","article-title":"Novel approaches to design glycan-based antibacterial inhibitors","volume":"26","author":"Behren","year":"2023","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0070","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.1002\/ange.201709368","article-title":"Covalent lectin inhibition and application in bacterial biofilm imaging","volume":"129","author":"Wagner","year":"2017","journal-title":"Angew Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0075","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1039\/D0PY00975J","article-title":"Catechol-functionalized sequence-defined glycomacromolecules as covalent inhibitors of bacterial adhesion","volume":"11","author":"Fischer","year":"2020","journal-title":"Polym Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0080","article-title":"The World Health Organization (WHO) fungal priority pathogens list in response to emerging fungal pathogens during the COVID-19 pandemic","volume":"28","author":"Editorial","year":"2022","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.bmc.2024.118020_b0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2024.118020_b0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10719-016-9726-7","article-title":"Blood group antigen expression is involved in C. albicans interaction with buccal epithelial cells","volume":"34","author":"Everest-Dass","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1016\/j.bmc.2024.118020_b0095","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41589-022-01035-1","article-title":"Mucin O-glycans are natural inhibitors of Candida albicans pathogenicity","volume":"18","author":"Takagi","year":"2022","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2024.118020_b0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejmech.2018.10.011","article-title":"Inhibition of adherence of the yeast Candida albicans to buccal epithelial cells by synthetic aromatic glycoconjugates","volume":"160","author":"Martin","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1021\/acs.bioconjchem.1c00115","article-title":"Multivalent presentations of glycomimetic inhibitor of the adhesion of fungal pathogen Candida albicans to human buccal epithelial cells","volume":"32","author":"Martin","year":"2021","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2024.118020_b0110","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1365-2958.2011.07676.x","article-title":"The N-terminal part of Als1 protein from Candida albicans specifically binds fucose-containing glycans","volume":"80","author":"Donohue","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmc.2024.118020_b0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2958.2008.06184.x","article-title":"Glycan microarray analysis of Candida glabrata adhesin ligand specificity","volume":"68","author":"Zupancic","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmc.2024.118020_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/jof4040119","article-title":"Adhesins of yeasts: protein structure and interactions","volume":"4","author":"Willaert","year":"2018","journal-title":"J Fungi"},{"key":"10.1016\/j.bmc.2024.118020_b0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2666-5247(23)00114-3","article-title":"Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern","volume":"4","author":"Kumar Mishra","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.bmc.2024.118020_b0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1039\/C6MD00017G","article-title":"Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-\u03b1-acetyl-\u029f-lysine as an amine nucleophile","volume":"7","author":"Dahal","year":"2016","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmc.2024.118020_b0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S1473550418000332","article-title":"Application of pulsed electric fields for the elimination of highly drug-resistant Candida grown under modelled microgravity conditions","volume":"18","author":"Lastauskiene","year":"2019","journal-title":"Int J Astrobiol"},{"key":"10.1016\/j.bmc.2024.118020_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhazmat.2014.12.027","article-title":"A novel method for comparison of biocidal properties of nanomaterials to bacteria, yeasts and algae","volume":"286","author":"Suppi","year":"2015","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.bmc.2024.118020_b0145","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/17435390.2019.1621401","article-title":"Toxicity of differently sized and charged silver nanoparticles to yeast Saccharomyces cerevisiae BY4741: a nano-biointeraction perspective","volume":"13","author":"Kasemets","year":"2019","journal-title":"Nanotoxicology"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:01:15Z","timestamp":1737777675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624004346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"alternative-id":["S0968089624004346"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118020","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of aromatic glycoconjugates as anti-fungal agents against Candida spp. and assessment of their covalent crosslinking capabilities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118020"}}